On September 26th, 2024, ARCH Venture Partners announced it had closed ARCH Venture Fund XIII, a venture capital fund with over $3 billion to support the launch and growth of early-stage biotech companies. This latest fund builds on ARCH’s longstanding goal of investing in transformative healthcare solutions, with a focus on advanced therapies, AI, and other cutting-edge solutions. [Read more…]
iPSC Market Leaders and their Business Models
Today, induced pluripotent stem cells (iPSCs) are being exploited for uses in drug discovery and development, toxicology screening, disease modelling, personalized medicine, cell-based therapeutics, and beyond. A fascinatingly diverse range of business models have been developed by market competitors to provide iPSC specific products, services, technologies, and therapies across the life science sector. [Read more…]
Is the CAR-T Cell Therapy Craze Driving Pharma Investment?
Without a doubt, the cell therapy industry is coming of age. In addition to growing numbers of cell therapy clinical trials, numerous cell therapy products have been approved by regulatory agencies worldwide and 150+ cell therapy companies are competing within the global marketplace. These metrics are extremely important because they indicate that the market for cell therapy products is expanding.
However, one of the most telling trends within the industry is a growing interest among Big Pharma in cell therapy companies. [Read more…]
Nucleus Biologics Launches QuickStart Media™: A Suite of Optimized Media Formulations That Provide a Head Start on Your Therapy Optimization
SAN DIEGO, August 08, 2024 — Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media and buffers for the cell and gene therapy industry, proudly announces the launch of a novel platform to expedite the formulation and manufacture of custom media. This platform, called QuickStart Media™, is a groundbreaking addition to its comprehensive line of cell culture products and solutions and further demonstrates Nucleus Biologics’ expertise and dedication to the delivery of custom cell culture media, buffers, reagents, and services simpler and faster. [Read more…]
The Latest Cell Therapy Industry Updates
Enjoy the latest cell therapy industry news below, summarized as of August 9th, 2024. [Read more…]
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 63
- Next Page »